<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0003">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Berges</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Denicolai</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tchoghandjian</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Baeza-Kallee</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Honore</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Figarella-Branger</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Braguer</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <year>2018</year>
  <article-title>Proscillaridin A exerts anti-tumor effects through GSK3Î² activation and alteration of microtubule dynamics in glioblastoma</article-title>. 
  <source>Cell Death Dis</source>. 
  <volume>9</volume>:
  <fpage>984</fpage>
  <pub-id pub-id-type="pmid">30250248</pub-id>
 </mixed-citation>
</ref>
